The $22 million investment from ATAI will develop the drug ibogaine which is derived from the iboga plant that has previously been sold as a stimulant …
$22 Million Joint Venture To Purse Neurochemical Reset For Addiction
A joint venture has been set up by ATAI Life Sciences and DemeRX to develop a one and done treatment that will work to give people suffering from addiction a neurochemical reset of sorts using a drug derived from a Western African plant.
The $22 million investment from ATAI will develop the drug ibogaine which is derived from the iboga plant that has previously been sold as a stimulant ...
Hallucinogenic Root Presented as Addiction Fighter at Davos
Unlike methadone, a substitute and therefore also an opioid, ibogaine is often referred to as addiction interrupter that appears to reset the brain …
Astronauts and addiction: Ending the stigma (op-ed)
Michael D. Shaw is a biochemist and freelance writer. A graduate of the University of California, Los Angeles, and a protégé of the late Willard Libby, winner of the 1960 Nobel Prize in chemistry, Shaw also did postgraduate work at the Massachusetts Institute of Technology. Based in Virginia, he covers technology, health care and entrepreneurship, among other topics.
Astronauts sometimes face the gravest threats after they return to Earth. Facing depression, alcoholism ...
Advertisement: Why this emerging industry is giving society a new lease on life
- The opioid epidemic has become a worldwide crisis, with more than 130 people dying every day from an overdose in the U.S. alone
- It’s not just the addict who’s affected. It’s their family and friends as well – and communities
- Universal Ibogaine Inc. has a plan to curb the number of opioid-related deaths through its plant-based treatment approach
North America has been ravaged by the opioid crisis ...